Intriguingly, this highlighted NAV3 as being upregulated in mesenchymally invading cells and downregulated in cells employing amoeboid invasion strategies in fibrosarcoma and melanoma cells (Figure 5B, Figure S3C), in line with results on GBM cells. The gene discussed is NAV3; the disease is glioblastoma.